Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses-Reference-Cited by-同舟云学术

Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses

Published:2022-05 Issue:9 Volume:39 Page:110901
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Hinke Daniëla Maria,Andersen Tor Kristian,Gopalakrishnan Ramakrishna Prabhu,Skullerud Lise Madelene,Werninghaus Ina Charlotta,Grødeland Gunnveig,Fossum Even,Braathen Ranveig^ORCID,Bogen Bjarne^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference66 articles.

1. Gene transfer into muscle by electroporation in vivo;Aihara;Nat. Biotechnol.,1998

2. Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules;Andersen;NPJ Vaccines,2019

3. Simultaneous targeting of multiple hemagglutinins to APCs for induction of broad immunity against influenza;Anderson;J. Immunol.,2018

4. Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells;Avalos;J. Exp. Med.,2014

5. B cells acquire antigen from target cells after synapse formation;Batista;Nature,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation;Vaccines;2024-04-17

2. Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins;Nature Communications;2024-02-12

3. STUDIES ON THE INTERACTION MECHANISM BETWEEN THE MRNA VACCINE AGAINST SARS-COV-2 AND THE IMMUNE SYSTEM;Journal of Applied Analysis & Computation;2024

4. A novel “prime and pull” strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge;Journal of Nanobiotechnology;2023-12-13

5. A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses;Scientific Reports;2023-11-02